Evaluation of the UltraClear Laser Workstation for Skin Treatment - Histology Study of Laser Ablation on Human Skin

NCT05202834 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2022-01-24

No results posted yet for this study

Summary

Evaluation of the UltraClear Laser Workstation for Skin Treatment - Histology Study of Laser Ablation on human skin

Conditions

  • Healthy

Interventions

DEVICE

UltraClear

Evaluation of the UltraClear Laser Workstation for Skin Treatment - Histology Study of Laser Ablation on human skin

Sponsors & Collaborators

  • FA Corporation

    lead INDUSTRY

Principal Investigators

  • Shlomo Assa · FA Corporation

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-15
Primary Completion
2021-10-12
Completion
2021-11-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05202834 on ClinicalTrials.gov